Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Subcutaneous and Intravenous Heparin Administration for Prevention of VTE in ICU
IRCT20240929063203N4Phase 3Completed
- Sponsor
- Hormozgan University of Medical Sciences
- Start
- Dec 2025
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of heparin in venous thromboembolism (VTE) (2 arms), sponsored by Hormozgan University of Medical Sciences. Started Dec 2025; status: completed.
02
Drugs
heparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on IRCT20240929063203N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240929063203N4.